Roberto Wandenkolk Vieira is President, Oncology at CORCEPT THERAPEUTICS INC (CORT). Vieira has reported 1 insider filing with the SEC since 2026. The most recent filing was in September 2026.
Every role Roberto Wandenkolk Vieira has reported on a Form 4, reconstructed from the filings themselves. Reporting insiders must state their relationship to the issuer (officer title, director seat, or 10% ownership) on every filing.
CORCEPT THERAPEUTICS INC (CORT)1 filingLatest filing:
Roberto Wandenkolk Vieira is President, Oncology of CORCEPT THERAPEUTICS INC (CORT). 1 SEC Form 4 filing on record, dated 4 September 2026. Most recent open-market trade: sold $141K of CORT on 4 September 2026. Lifetime open-market sales: $6.46M.
Every recent SEC Form 4 transaction Roberto Wandenkolk Vieira has reported, most recent first.
InsiderAlpha's records for Roberto Wandenkolk Vieira go back to 2026: 1 primary Form 4 filing, an average of 1.0 per year. 12 recorded transactions carry a Rule 10b5-1 plan flag. This identifies the marked transactions as reported under a trading plan; it does not establish the plan status of unmarked transactions.
Insiders who reported open-market trades in the last 12 months at the companies Roberto Wandenkolk Vieira files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Roberto Wandenkolk Vieira is a corporate insider, tracked as President, Oncology of CORCEPT THERAPEUTICS INC (CORT). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
1 primary Form 4 filing in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases and 7 open-market sales ($6.46M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial